Financial Performance - Revenue for Q1 2025 was $134.5 million, a decrease of 3.8% from $139.8 million in Q4 2024[3] - Net income attributable to common stockholders was $39.8 million, down 13.2% from $45.8 million in the previous quarter[3] - Diluted earnings per share (EPS) decreased to $0.77, a decline of 12.7% from $0.89 in Q4 2024[3] - Total revenue for Q1 2025 was $134.467 million, a decrease of 3.8% from Q4 2024 but an increase of 9.6% year-over-year[20] - Net income attributable to common stockholders for Q1 2025 was $39.778 million, down 13.2% from Q4 2024 but up 17.0% from Q1 2024[20] - Diluted earnings per share (EPS) for Q1 2025 was $0.77, a decrease of 13.5% from $0.89 in Q4 2024, and an increase of 13.2% from $0.68 in Q1 2024[27] - Adjusted operating income for Q1 2025 was $46,446,000, down 6.4% from $49,708,000 in Q4 2024, and up 6.4% from $43,692,000 in Q1 2024[30] - Operating margin for Q1 2025 was 33.6%, down from 35.3% in Q4 2024, representing a decline of 170 basis points[7] - Operating margin as adjusted for Q1 2025 was 34.7%, compared to 35.5% in Q4 2024 and 35.5% in Q1 2024[30] Assets Under Management (AUM) - Total assets under management (AUM) reached $87.6 billion, reflecting a 2.1% increase from $85.8 billion at the end of 2024[11] - Assets under management at the end of Q1 2025 increased to $87.579 billion, reflecting a 2.1% increase from Q4 2024 and a 7.8% increase year-over-year[22] - Average AUM decreased by 3.0% to $86,778 million compared to the previous quarter, but increased by 8.2% year-over-year[25] - Assets under management (AUM) for institutional accounts increased to $33,886 million, reflecting a 1.0% increase from December 31, 2024, and a 4.5% increase from March 31, 2024[23] - U.S. Real Estate AUM rose to $43,591 million, a 1.5% increase from December 31, 2024, and a 13.3% increase from March 31, 2024[24] - Global Listed Infrastructure AUM increased to $9,710 million, marking a 10.4% increase from December 31, 2024, and a 15.7% increase from March 31, 2024[25] Inflows and Outflows - Net inflows amounted to $222 million, contributing to the increase in AUM[11] - The company experienced net inflows of $222 million in Q1 2025, compared to net inflows of $860 million in Q4 2024[22] - Total net inflows for the company were $222 million, compared to net outflows of $1,970 million in the same period last year[25] - The company reported net outflows of $366 million in institutional accounts, a decrease from $2,543 million in the same period last year[23] Expenses - Employee compensation and benefits decreased by 3.5% to $54.6 million compared to $56.5 million in the previous quarter[6] - General and administrative expenses increased by 8.8% to $17.2 million, primarily due to non-recurring expenses[6] - Employee compensation and benefits expenses were $54.554 million in Q1 2025, a decrease of 3.4% from Q4 2024[20] Tax and Non-Operating Income - Effective income tax rate for Q1 2025 was 19.5%, down from 21.7% in Q4 2024[10] - The company reported a total non-operating income of $7.752 million for Q1 2025, a 21.7% increase from Q4 2024 and a 53.9% increase year-over-year[20] - Non-operating income for Q1 2025 was $7,752,000, an increase of 21.7% from $6,368,000 in Q4 2024, and an increase of 54.0% from $5,037,000 in Q1 2024[32] Currency and Adjustments - The company reported a foreign currency exchange gain of $969,000 in Q1 2025, compared to a loss of $(2,824,000) in Q4 2024 and a loss of $(456,000) in Q1 2024[32] - Total tax adjustments for Q1 2025 amounted to $(3,329,000), compared to $(994,000) in Q4 2024 and $(910,000) in Q1 2024[29] Future Outlook - The company anticipates continued growth in assets under management driven by market appreciation and strategic inflows[18]

NEW YORK, April 16, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported its results for the quarter ended March 31, 2025. The earnings release along with the accompanying earnings presentation can be viewed at Cohen & Steers Reports Results for First Quarter 2025 and on the company's website at www.cohenandsteers.com under "Company—Investor Relations—Earnings Archive."Conference CallThe company will host a conference call tomorrow, Thursday, April 17, 2025, at 10:00 a.m. (ET) to discuss the ...

Core Viewpoint - Cohen & Steers, Inc. is set to release its first quarter 2025 results on April 16, 2025, after market close, with a conference call scheduled for April 17, 2025, to discuss the results and outlook [1][2]. Company Information - Cohen & Steers is a prominent global investment manager that specializes in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, and commodities [3]. - The firm was founded in 1986 and is headquartered in New York City, with additional offices in London, Dublin, Hong Kong, Tokyo, and Singapore [3].

Core Insights - Cohen & Steers, Inc. reported preliminary assets under management (AUM) of $87.6 billion as of March 31, 2025, reflecting a decrease of $979 million from $88.6 billion at February 28, 2025 [1][2] AUM Breakdown - The decrease in AUM was attributed to market depreciation of $1.1 billion and distributions totaling $301 million, which were partially offset by net inflows of $452 million [1][2] - AUM by investment vehicle as of March 31, 2025: - Institutional Accounts: Total AUM decreased to $33.886 billion, with advisory accounts at $19.703 billion, Japan subadvisory at $8.534 billion, and subadvisory excluding Japan at $5.649 billion [2] - Open-end Funds: AUM decreased to $42.298 billion [2] - Closed-end Funds: AUM decreased to $11.395 billion [2] Company Overview - Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, and commodities [2] - The firm was founded in 1986 and is headquartered in New York City, with additional offices in London, Dublin, Hong Kong, Tokyo, and Singapore [2]

Core Insights - Corero Network Security has formed a strategic partnership with Brazil-based TechEnabler to enhance its DDoS Protection-as-a-Service (DDPaaS) solution with the addition of Corero 3400 400G appliances [1][2] - The partnership is part of Corero's recent success in Brazil, securing four deals totaling over $2 million in the past four months [1] - TechEnabler will utilize Corero's SmartWall ONE™ DDoS protection solutions to provide managed security services across Latin America, addressing the increasing demand for scalable DDoS mitigation strategies [2][3] Company Developments - Corero's CEO, Carl Herberger, emphasized the global demand for automated DDoS protection and the importance of the partnership with TechEnabler as a means to expand its presence in Latin America [3] - In addition to TechEnabler, Corero has signed agreements with DigitalnetBR and Forte Telecom, showcasing its commitment to providing high-performance DDoS defense technology tailored for complex network environments [3] Company Overview - Corero Network Security specializes in automatic detection and protection solutions against DDoS threats, ensuring internet service availability [4] - The company operates from its headquarters in London, with operational centers in Marlborough, Massachusetts, and Edinburgh, UK, and is listed on the London Stock Exchange's AIM market and the US OTCQX Market [4]

Core Insights - Corero Network Security has expanded its partnership with Juniper Networks, allowing Juniper to sell Corero's complete DDoS protection suite to a wider range of customers [1][2] - The partnership enables Juniper to offer advanced DDoS protection solutions, including SmartWall ONE™ and the cloud-native CORE platform, enhancing security capabilities for organizations [2][3] - This collaboration is particularly beneficial for customers operating in mixed network environments, as it provides robust DDoS protection without the need for costly infrastructure changes [3] Company Overview - Corero Network Security specializes in DDoS protection solutions, focusing on automatic detection and protection with network visibility, analytics, and reporting tools [3] - The company is headquartered in London and operates centers in Marlborough, Massachusetts, USA, and Edinburgh, UK, and is listed on the London Stock Exchange's AIM market and the US OTCQX Market [3]

NEW YORK, March 27, 2025 /PRNewswire/ -- The Boards of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for April, May and June 2025, as summarized in the charts below: Ticker Fund Name MonthlyDividend FOF Cohen & Steers Closed-End Opportunity Fund, Inc. $0.087 LDP Cohen & Steers Limited Duration Preferred and Income Fund, Inc. $0.131 PSF Cohen & Steers Select Preferred and Income Fund, Inc. $0.126 PTA Cohen & Steers Tax-Advantaged Preferred S ...

CNS Pharmaceuticals, Inc. CNSP on Tuesday announced the primary analysis of its clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM), an aggressive form of brain cancer.The trial compared Berubicin to Lomustine, a current standard of care in recurrent or progressive GBM.This analysis did not demonstrate statistically significant superiority in overall survival, the primary endpoint.Additionally, patients experienced no cardiotoxicity, a risk that curtails the use of ...

NEW YORK, March 24, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that the Cohen & Steers Real Estate Securities Fund (CSZIX) has received a 2025 LSEG Lipper Fund Award for its strong risk-adjusted performance over the 10-year period, ended November 30, 2024. This is the tenth consecutive year Lipper has recognized the Fund. For 2025, the Real Estate category for the 10-year period included 136 share classes. Jason Yablon, Head of Listed Real Estate, said:"We are honored to be recogn ...

Core Insights - Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to developing therapeutics for patients with high unmet medical needs [3] Group 1: Company Presentation - Xenon Pharmaceuticals will present at the Stifel 2025 Virtual CNS Forum on March 18-19, 2025 [1] - The presentation will feature Dr. Chris Kenney, Chief Medical Officer, on March 19, 2025, from 12:00-12:25 PM Eastern Time [2] - A live audio webcast of the presentation will be available on the company's website and will be posted for replay after the event [2] Group 2: Product Development - The company is advancing an ion channel product portfolio targeting conditions such as epilepsy and depression [3] - Azetukalner is highlighted as a novel, highly potent, selective Kv7 potassium channel opener, currently in late-stage clinical development for multiple indications [3]